These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3919988)

  • 1. Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow.
    Svensson CK; Cumella JC; Tronolone M; Middleton E; Lalka D
    Clin Pharmacol Ther; 1985 Apr; 37(4):464-8. PubMed ID: 3919988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbohydrates on estimated hepatic blood flow.
    Svensson CK; Mauriello PM; Barde SH; Middleton E; Lalka D
    Clin Pharmacol Ther; 1984 May; 35(5):660-5. PubMed ID: 6713776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.
    Svensson CK; Edwards DJ; Mauriello PM; Barde SH; Foster AC; Lanc RA; Middleton E; Lalka D
    Clin Pharmacol Ther; 1983 Sep; 34(3):316-23. PubMed ID: 6883907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food on blood hydralazine levels and response in hypertension.
    Shepherd AM; Irvine NA; Ludden TM
    Clin Pharmacol Ther; 1984 Jul; 36(1):14-8. PubMed ID: 6734044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of intravenous nicardipine, prostaglandin E1, nitroglycerin, sodium nitroprusside, and epidural lidocaine on hepatic and renal blood flow during hypotensive anesthesia].
    Tabo E; Yorozuya T; Shimizu I; Adachi N; Nagaro T; Arai T
    Masui; 2000 Dec; 49(12):1333-8. PubMed ID: 11193508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin attenuates the hypotensive action of hydralazine.
    Cinquegrani MP; Liang CS
    Clin Pharmacol Ther; 1986 May; 39(5):564-70. PubMed ID: 3698464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic vascular pooling potency of vasodilator drugs (nitroglycerin, phentolamine, hydralazine).
    Strauer BE; Scherpe A
    Am Heart J; 1979 Mar; 97(3):408-9. PubMed ID: 105616
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
    Panzenbeck M; Baez A; Kaley G
    J Pharmacol Exp Ther; 1986 May; 237(2):525-8. PubMed ID: 3084759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food and nicotine metabolism.
    Lee BL; Jacob P; Jarvik ME; Benowitz NL
    Pharmacol Biochem Behav; 1989 Jul; 33(3):621-5. PubMed ID: 2587604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hydralazine on regional blood flow in conscious dogs.
    Chelly JE; Doursout MF; Begaud B; Tsao CC; Hartley CJ
    J Pharmacol Exp Ther; 1986 Aug; 238(2):665-9. PubMed ID: 3735136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydralazine on the elimination of antipyrine in the rat.
    Svensson CK; Knowlton PW; Ware JA
    Pharm Res; 1987 Dec; 4(6):515-8. PubMed ID: 3508566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
    Mehta J; Pepine CJ; Conti CR
    Clin Cardiol; 1978 Aug; 1(2):68-73. PubMed ID: 116791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
    Bauer LA; Stenwall M; Horn JR; Davis R; Opheim K; Greene L
    Clin Pharmacol Ther; 1986 Aug; 40(2):239-42. PubMed ID: 3731687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of hydralazine on perfusion of KHT tumor, kidney and liver and on renal function in mice.
    Honess DJ; Bleehen NM
    Int J Radiat Oncol Biol Phys; 1992; 22(5):953-61. PubMed ID: 1555988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.